MD Anderson will expand its support of IAEA through a jointly developed work plan that includes:

Training and educational activities in radiation oncology, radiation physics, radiology, nuclear medicine and nutrition.
Technical expertise and assistance in expanding scientific and technical capabilities in radiotherapy and radiology.

Research collaborations, for example, quality assurance of dosimetry auditing methodologies.
Collaboration in the Rays of Hope initiative of the IAEA through Anchor Centres.
Participation in the cost-free experts program of the IAEA through the provision of technical experts.
"We are honored to be designated as an IAEA Collaborating Centre. This recognition not only validates the work we’ve already completed to advance global initiatives in cancer research and treatment but also inspires us with the possibilities ahead through these collaborative opportunities,” said Kathleen Schmeler, M.D., associate vice president of Global Oncology and professor of Gynecologic Oncology and Reproductive Medicine. “We look forward to working together with the IAEA and their Member State institutions to make significant strides for cancer patients and their families around the world."

MD Anderson’s Strategic Plan calls for reaching more people and saving more lives, which is advanced by aligning with others to provide expertise in cancer prevention, education, research and treatment in the community setting. Today’s announcement further extends MD Anderson's commitment to this work, which includes its international collaboration to reduce the global burden of women’s cancers with the WHO.

Aligned with the goals of World Cancer Day on February 4, MD Anderson’s efforts echo the broader mission of the international awareness day to alleviate the global impact of cancer while highlighting the need to take concerted actions to recognize, understand and resolve disparities in cancer care on a global level.

Back to HCB News

Molecular Imaging Homepage